Shi, Michael
Novartis International AG,
United States
2024 Rank: 128,649
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4,884 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 128,649 | 144,792 |
| Total Cites | 12,597 | 14,081 |
| H-index | 33 | 33 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 295 | 295 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 1,023 | 1,106 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 1,114 | 1,200 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,196 | 12,424 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.13 |
| Self-Citation Percentage |
10.54%
|
|
Shi, Michael
Novartis International AG,
United States
2023 Rank: 121,200
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4,692 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 121,200 | 136,512 |
| Total Cites | 12,234 | 13,714 |
| H-index | 33 | 33 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 293 | 293 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 1,010 | 1,093 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 1,093 | 1,179 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,856 | 12,078 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
10.79%
|
|
Shi, Michael
Novartis International AG,
United States
2022 Rank: 110,187
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4,311 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 110,187 | 124,598 |
| Total Cites | 11,763 | 13,224 |
| H-index | 33 | 33 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 289 | 289 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 1,002 | 1,085 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 1,075 | 1,161 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,413 | 11,620 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
11.05%
|
|
Shi, Michael
Novartis International AG,
United States
2021 Rank: 104,997
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4,135 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104,997 | 118,827 |
| Total Cites | 11,288 | 12,702 |
| H-index | 33 | 33 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 287 | 287 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 993 | 1,076 |
| Number of Single+First+Last Authored Papers | 22 | 22 |
| Total Cites to Single+First+Last Authored Papers | 1,059 | 1,145 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10,002 | 11,172 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
11.13%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.